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	ABSTRACT		(Word	count:	254	/	275)	Many	medical	decisions	involve	the	use	of	dynamic	information	collected	on	individual	patients	toward	predicting	likely	transitions	in	their	future	health	status.	If	accurate	predictions	are	developed,	then	a	prognostic	model	can	identify	patients	at	greatest	risk	for	future	adverse	events,	and	may	be	used	clinically	to	define	populations	appropriate	for	targeted	intervention.	In	practice,	a	prognostic	model	is	often	used	to	guide	decisions	at	multiple	time	points	over	the	course	of	disease,	and	classification	performance,	i.e.	sensitivity	and	specificity,	for	distinguishing	high-risk	versus	low-risk	individuals	may	vary	over	time	as	an	individual’s	disease	status	and	prognostic	information	change.	In	this	tutorial,	we	detail	contemporary	statistical	methods	that	can	characterize	the	time-varying	accuracy	of	prognostic	survival	models	when	used	for	dynamic	decision-making.	Although	statistical	methods	for	evaluating	prognostic	models	with	simple	binary	outcomes	are	well	established,	methods	appropriate	for	survival	outcomes	are	less	well	known	and	require	time-dependent	extensions	of	sensitivity	and	specificity	to	fully	characterize	longitudinal	biomarkers	or	models.			The	methods	we	review	are	particularly	important	in	that	they	allow	for	appropriate	handling	of	censored	outcomes	commonly	encountered	with	event-time	data.	We	highlight	the	importance	of	determining	whether	clinical	interest	is	in	predicting	cumulative	(or	prevalent)	cases	over	a	fixed	future	time	interval	versus	predicting	incident	cases	over	a	range	of	follow-up	times,	and	whether	patient	information	is	static	or	updated	over	time.	We	discuss	implementation	of	time-dependent	ROC	approaches	using	relevant	R	statistical	software	packages.	The	statistical	summaries	are	illustrated	using	a	liver	prognostic	model	to	guide	transplantation	in	primary	biliary	cirrhosis. 	
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1	Introduction	Many	medical	decisions	involve	using	updated	information	on	patients	under	surveillance	to	predict	transitions	in	future	health	status,	such	as	progression	of	disease	or	advancement	to	death.	The	goal	is	to	use	a	patient’s	clinical	characteristics	to	calculate	the	predicted	risk	of	an	event	within	a	specified	time	period	and	to	identify	patients	who	are	at	high	risk	of	experiencing	an	adverse	event	in	the	near	future.	If	accurate	predictions	can	be	made,	they	could	be	used	clinically	to	guide	the	choice	and	timing	of	interventions	and	enable	timely	action,	such	as	starting	specific	preventive	strategies	or	initiating	aggressive	treatments	for	high-risk	individuals	while	sparing	low-risk	patients	the	side-effects	and	costs	of	unnecessary	intervention.		In	practice,	prognostic	models	are	often	used	to	make	decisions	at	multiple	time	points	over	the	course	of	patient	follow-up.	Consider	disease	screening	settings,	where	predicted	risk	may	be	used	to	identify	high-risk	individuals	as	candidates	for	more	frequent	screening.	Patient	follow-up	with	updated	clinical	assessment	also	frequently	occurs	to	monitor	response	to	therapy.	For	example,	a	cancer	patient	who	has	previously	undergone	treatment	and	is	predicted	to	be	at	substantial	risk	of	disease	recurrence	may	benefit	from	adjuvant	therapy,	whereas	a	low-risk	patient	may	forego	aggressive	treatment.	Finally,	in	an	organ	transplantation	setting,	the	predicted	risk	of	mortality	may	be	used	to	guide	prioritization	and	timing	of	donor	organ	transplantation.1-3	Traditional	statistical	models	such	as	Cox	regression	focus	on	the	prediction	of	disease	or	death	times.		However,	underlying	these	standard	methods	are	the	concepts	of	a	time-varying	“risk	set”	of	individuals,	and	associated	time-specific	“cases”	or	subjects	who	experience	the	clinical	event	(ie.	death)	at	a	given	time.		At	any	time	point,	the	set	of	individuals	still	alive	and	at	risk	of	an	event	may	be	partitioned	into	imminent	“cases”	(individuals	who	experience	the	event	in	a	defined	future	time	frame)	and	current	“controls”	(individuals	who	do	not	yet	experience	the	event).	Ultimately,	the	goal	of	a	prognostic	model	is	to	accurately	predict	event	times,	or	equivalently	to	distinguish	between	the	time-specific	cases	and	the	controls	at	all	follow-up	times.	Furthermore,	in	practice	an	individual’s	disease	status	changes	over	time,	and	so	does	his	or	her	prognostic	information,	such	as	laboratory	measures	updated	in	routine	clinic	visits.	Accordingly,	a	
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model’s	ability	to	distinguish	between	cases	and	controls	over	time	may	also	change,	thus	impacting	its	performance	as	a	decision-making	tool.	For	example,	a	prognostic	model	may	accurately	identify	patients	at	high	risk	of	death	within	90	days,	but	it	may	have	reduced	accuracy	for	identifying	later	deaths.		Accuracy	concepts	of	sensitivity	and	specificity	are	fundamental	to	clinical	research	and	decision	modeling.	Only	recently	have	statistical	methods	been	developed	that	can	generalize	these	traditionally	cross-sectional	accuracy	concepts	for	application	to	the	time-varying	nature	of	disease	states,	and	corresponding	definitions	of	time-dependent	sensitivity	and	specificity	have	been	proposed	for	both	prevalent	and	incident	case	definitions.2,3		These	new	concepts	and	associated	statistical	methods	are	central	to	the	evaluation	of	the	time-varying	performance	of	any	potential	prognostic	model;	they	allow	for	the	estimation	of	sensitivity,	specificity	and	area	under	the	receiver	operating	characteristic	(ROC)	curve	(AUC)	as	functions	of	time,	thus	providing	a	detailed	estimate	of	longitudinal	model	performance	for	use	in	practice.	These	methods	are	particularly	important	in	that	they	allow	for	appropriate	handling	of	right-censored	outcomes	commonly	encountered	with	clinical	event	time	data.		Unfortunately,	knowledge	of	these	methods	and	the	tools	available	to	implement	them	remains	limited,	and	investigators	often	resort	to	overly	simplistic	application	of	methods	developed	for	binary	outcomes,	which	can	lead	to	biased	estimates	in	the	presence	of	censoring.4-5	Our	goal	in	this	tutorial	is	to	demonstrate	the	use	of	modern	statistical	methods	that	address	the	following	questions:	how	can	the	time-varying	discrimination	accuracy	of	a	prognostic	model	be	evaluated;	how	can	the	value	of	updated	measurements	be	characterized;	and	how	can	different	candidate	models	be	directly	compared?	We	highlight	the	importance	of	determining	whether	interest	is	in	the	fundamental	epidemiologic	concept	of	predicting	cumulative	(or	prevalent)	cases,	or	in	incident	cases.			
1.1	Case	study:	Liver	Prognostic	Model	to	Guide	Transplantation	in	Primary	Biliary	
Cirrhosis	As	an	illustrative	case	study,	we	consider	liver	transplantation	in	primary	biliary	cirrhosis	(PBC).	PBC	is	an	autoimmune	disease	in	which	the	bile	ducts	are	slowly	destroyed,	leading	to	liver	failure	in	cases	of	advanced	disease.6	For	selected	patients	with	liver	failure	who	
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are	at	high	risk	of	death	without	transplantation,	liver	transplantation	can	be	potentially	life-saving.	As	a	result,	a	number	of	prognostic	models	have	been	developed	in	PBC,	with	the	goal	of	predicting	survival	probabilities	and	guiding	decisions	regarding	transplantation.7-13	Of	these,	the	Mayo	model	is	perhaps	the	most	widely	known7	with	the	more	recent	Model	for	End-stage	Liver	Disease	(MELD)	score2	representing	a	refinement,	but	potentially	suboptimal	for	use	in	PBC.7	A	unique	characteristic	of	the	Mayo	model	compared	to	other	existing	models	is	that	it	does	not	require	liver	biopsy.	Instead,	it	is	based	on	inexpensive,	noninvasive	and	readily	available	measurements.	Additional	variables	from	a	biopsy,	such	as	histologic	stage,	that	are	used	in	other	models	have	been	shown	to	not	contribute	substantially	beyond	the	variables	included	in	the	Mayo	model.1	We	consider	a	well-known	dataset	that	comes	from	a	randomized	placebo-controlled	trial	for	the	treatment	of	PBC	conducted	at	the	Mayo	Clinic	between	1974	and	1984.14	Dickson	et	al.1	used	this	data	to	develop	the	Mayo	risk	model	that	included	patient	age,	total	serum	bilirubin	and	serum	albumin	concentrations,	prothrombin	time,	and	severity	of	edema.	This	model	has	been	used	for	making	individual-level	decisions	regarding	the	selection	of	patients	for	and	timing	of	liver	transplantation	in	PBC.7	Decisions	about	transplantation	are	made	repeatedly	over	time,	by	selecting	patients	who	are	most	likely	to	die	in	a	short	time	interval,	such	as	90	days,	6	months	or	1	year	from	the	time	of	prediction.	We	will	use	the	five	main	predictors	of	survival	identified	by	Dickson	et	al.1	to	calculate	the	predicted	risk	of	mortality	within	specified	time	periods,	and	evaluate	the	accuracy	of	these	predictions	for	prioritizing	patients	for	transplantation.		
	
1.2	Model	Development	Model	development	typically	takes	place	by	splitting	a	dataset	into	training	and	validation	data	that	are	used	for	model	selection	and	evaluation,	respectively.	Using	appropriate	methods	to	avoid	overfitting	in	the	training	data,15-17	candidate	biomarkers	and	variables	are	selected	and	combined,	traditionally	using	a	Cox	proportional	hazards	regression	model	for	survival	outcomes.18	One	may	use	standard	Cox	regression	with	fixed	coefficients	and	baseline	covariates,	or	even	incorporate	time-varying	covariates,	as	well	as	time-varying	coefficients	into	the	model.19	Alternatively,	one	may	use	more	flexible,	modern	machine-learning	approaches,	such	as	boosting,	lasso,	artificial	neural	networks,	and	
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random	forests,	especially	in	the	presence	of	high-dimensional	data.20-26	Regardless	of	the	chosen	modeling	approach,	the	ultimate	prognostic	model	is	then	fixed	and	used	in	the	validation	data	to	provide	patient	predictions	of	the	disease	outcome,	i.e.	a	risk	score.			 In	this	manuscript,	we	are	agnostic	to	model	selection.	We	focus	on	methods	for	evaluating	any	single	“biomarker”,	which	may	be	a	novel	predictive	measurement,	such	as	a	specific	serum	protein	level	measured	in	the	laboratory,	or	more	commonly	may	be	the	risk	score	derived	from	a	model	that	includes	multiple	factors,	i.e.	a	derived	biomarker	or	classifier.	The	approaches	we	discuss	for	evaluating	a	risk	score	in	the	validation	data	are	independent	of	those	used	for	model	selection	in	the	training	data,	in	that	they	do	not	rely	on	the	assumptions	that	may	be	necessary	for	the	development	of	the	risk	score.		Given	our	focus	on	model	evaluation,	it	is	not	our	objective	here	to	develop	a	new	model	as	an	alternative	to	the	Mayo	model.	We	simply	demonstrate	how	to	evaluate	the	time-varying	performance	of	the	existing	Mayo	risk	score,	as	well	as	one	variation	of	it	where	we	omit	a	variable,	in	order	to	demonstrate	a	comparison	of	two	candidate	models.			
2	Background:	Standard	Measures	of	Discrimination	Accuracy	The	traditional	classification	problem	is	based	on	a	simple	binary	outcome,	typically	the	presence	or	absence	of	disease.	In	classifying	cases	and	controls	as	having	disease	or	not,	a	marker	is	prone	to	two	types	of	error:	incorrectly	classifying	a	case	as	not	having	disease,	leading	to	delays	in	treatment,	and	conversely,	incorrectly	classifying	a	control	as	having	disease,	subjecting	the	individual	to	unnecessary	follow-up	medical	procedures.	Investigators	aim	to	minimize	false	negative	and	false	positive	errors	by	developing	markers	with	high	sensitivity	(true	positive	fraction	(TPF))	and	high	specificity	(1	minus	false	positive	fraction	(FPF)),	respectively.		By	convention,	larger	marker	values	are	assumed	to	be	more	indicative	of	disease	(and	if	the	opposite	is	true,	the	marker	is	transformed	to	fit	the	convention).	For	a	continuous	marker	M	and	a	fixed	threshold	c,	we	define	sensitivity(c)	=	P(M	>	c	|	case),	specificity(c)	=	P(M	≤	c	|	control).	
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The	Receiver	Operating	Characteristic	(ROC)	curve	is	a	standard	tool	that	plots	a	continuous	marker's	sensitivity	against	1-specificity	for	all	possible	values	of	the	threshold	
c.27-30	Classification	accuracy	is	most	commonly	summarized	using	the	area	under	the	ROC	curve	(AUC),	which	is	the	probability	that	a	randomly	chosen	case	has	a	higher	marker	value	than	a	randomly	chosen	control:		AUC	=	P(Mi	>	Mj	|	i	=	case,	j	=	control).	Therefore,	the	AUC	represents	the	marker’s	ability	to	rank	cases	above	controls.	An	AUC	of	0.5	indicates	no	discrimination	between	cases	and	controls,	whereas	an	AUC	of	1.0	indicates	perfect	discrimination.30	
	
3	Time-Dependent	Discrimination	Accuracy	Implicit	in	the	use	of	traditional	diagnostic	sensitivity	and	specificity	are	current-status	definitions	of	disease.		In	settings	of	long-term	follow-up,	disease	status	changes	with	time	and	precise	definitions	are	necessary	to	include	event	(disease)	timing	in	definitions	of	prognostic	error	rates.	Within	the	last	two	decades,	time-dependent	ROC	curve	methods	that	extend	concepts	of	sensitivity	and	specificity	and	characterize	prognostic	accuracy	for	survival	outcomes	have	been	proposed	in	the	statistical	literature	and	adopted	in	practice.	We	review	two	such	time-dependent	approaches,	which	draw	upon	alternative	fundamental	case	definitions:	cumulative	(or	prevalent)	cases;	and	incident	cases.	
	
3.1	Cumulative	(Prevalent)	Cases	/	Dynamic	Controls	Often	interest	lies	in	identifying	individuals	at	risk	of	an	adverse	event	within	some	fixed	time	frame.	Recall,	for	example,	decisions	about	donor	liver	allocation	in	the	PBC	setting	being	made	by	selecting	patients	who	are	most	likely	to	die	in	a	short	time	interval,	such	as	90	days,	6	months	or	1	year,	from	the	time	of	prediction.	A	natural	extension	of	the	standard	cross-sectional	definitions	of	sensitivity	and	specificity	to	the	survival	context,	where	disease	state	is	time-dependent,	is	to	dichotomize	the	outcome	at	a	selected	time	of	interest,	t	(90	days,	6	months	or	1	year),	and	define	cases	as	subjects	who	experience	the	event	before	time	t,	and	controls	as	those	who	remain	event-free	beyond	t.31	More	formally,	we	let	T	denote	survival	time	and	s	denote	the	start	
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time	of	case	ascertainment	(often	s=0	for	baseline).	Then,	cumulative	cases	(C)	may	be	defined	as	subjects	who	experience	an	event	prior	to	t,	or	specifically	as	Ti	!(s,t),	and	dynamic	controls	(D)	as	subjects	who	are	event-free	at	time	t,	Ti	>	t	(regardless	of	whether	or	not	they	experience	the	event	at	a	later	time).	Then	for	a	fixed	threshold	c,	time-dependent	definitions	for	sensitivity	and	specificity	follow31,32:			sensitivityC(c	|	start	=	s,	stop	=	t)	=	P(M	>	c	|	T	≥	s	,	T	≤	t)	specificityD(c	|	start	=	s,	stop	=	t)	=	P(M	≤	c	|	T	≥	s	,	T	>	t)	Let	p	represent	a	fixed	FPF.	Then,	for	fixed	specificityD(c|s,t)	=	1	-	p,	the	time-dependent	ROC	value	is	the	corresponding	value	of	sensitivityC(c|s,t),	or	ROCs,tC/D(p).	Correspondingly,	the	time-specific	AUC	is	defined	as	the	area	under	the	time-specific	ROC	curve	across	all	thresholds	p:	 AUCC/D(s,	t)	=	ò	ROCs,tC/D(p)	dp	which	can	be	shown	to	be	equivalent	to	AUCC/D(s,	t)	=	P(Mj	>	Mk	|	Tj	≥	s,	Tj	≤	t,	Tk	≥	s,	Tk	>	t).	Here,	AUCC/D(s,t)	is	the	probability	that	a	random	subject	j	who	experiences	an	event	before	time	t	(case)	has	a	larger	marker	value	than	a	random	subject	k	who	remains	event-free	through	time	t	(control),	assuming	both	subjects	are	event-free	at	the	start	of	follow-up,	time	s.		In	the	absence	of	censoring,	the	above	dichotomization	at	time	t	is	equivalent	to	using	a	simple	derived	binary	disease	outcome.	However	when	follow-up	is	incomplete,	as	is	often	the	case	with	longitudinal	data,	censoring	needs	to	be	addressed	and	can	be	handled	using	nonparametric	estimation	of	the	bivariate	distribution	of	(M,T).31	(See	Appendix	A	for	description	of	estimation	methods).	Estimation	is	based	on	("#, %#),	where	"#	is	the	observed	follow-up	time,	i.e.	the	minimum	of	the	survival	time	Ti	and	the	right	censoring	time	Ci,	and	d	i	denotes	the	event	indicator.	In	this	tutorial,	we	seek	to	characterize	time-varying	performance	over	a	meaningful	range	of	times.	To	this	end,	we	suggest	obtaining	a	sequence	of	accuracy	assessments	over	time	by	defining	cases	as	events	occurring	cumulatively	in	successive	windows	of	time.	Specifically,	we	subset	data	at	a	sequence	of	index	times	s	=	t1,	t2,	…,	tK	to	include	only	subjects	who	are	event-free	at	time	tk,	i.e.	Z	≥	tk,	k=1,...,K.	These	index	times	can	represent	
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any	time	points	of	interest	and	do	not	have	to	fall	at	constant	time	intervals.	For	each	subsetted	dataset,	we	suggest	conducting	a	separate	analysis,	treating	tk,	k=1,...,K,	as	the	new	baseline	s	and	defining	cases	cumulatively	as	subjects	who	have	events	over	the	following,	say,	1-year	span,	so	that	"# ∈ (( = *+, * = *+ + 1)	and	di=1,	and	defining	controls	such	that	Zi	>	tk	+	1	(Figure	1).	A	series	of	accuracy	summaries,	such	as	AUCC/D(0,	1),	AUCC/D(2,	3),	AUCC/D(4,	5),	...,	is	obtained,	and	time-varying	accuracy	is	indicated	by	a	change	in	AUCs	over	time.	The	same	idea	can	be	applied	to	obtain	time-varying	sensitivity	and	specificity.		If	prognostic	information	changes	over	time,	updated	information	can	be	included	in	each	subsetted	analysis	by	using	the	last	measured	information	to	obtain	updated	risk	predictions.	Although	we	chose	a	1-year	cumulative	window	for	illustration,	the	window	is	flexible	and	may	be	chosen	to	be	more	clinically	meaningful	depending	on	the	disease	setting.	Alternatively,	the	incident/dynamic	approach,	discussed	next,	provides	a	finer	timescale,	allowing	for	a	smoother	characterization	of	performance	over	time	without	having	to	specify	a	window	of	time	over	which	cases	accumulate.		
3.2	Incident	Cases	/	Dynamic	Controls	Survival	analysis	using	Cox	regression	is	based	on	the	fundamental	concept	of	a	risk	set:	a	risk	set	at	time	t	consists	of	the	cases	experiencing	events	at	time	t,	and	the	additional	individuals	who	are	under	study	(alive)	but	do	not	yet	experience	the	clinical	event.		Extension	of	binary	classification	error	concepts	to	risk	sets	leads	naturally	to	adopting	an	incident	(I)	case	definition	where	subjects	who	experience	an	event	at	time	t	or	have	survival	time	Ti	=	t	are	the	time-specific	cases	of	interest.	Dynamic	controls	(D)	can	be	compared	to	incident	cases	and	are	subjects	with	Ti	>	t	(regardless	of	whether	or	not	they	experience	the	event	or	get	censored	at	a	later	time).	In	this	scenario,	time-dependent	definitions	for	sensitivity	and	specificity	are33:	sensitivityI(c	|	t)	=	P(M	>	c	|	T	=	t)	specificityD(c	|	t)	=	P(M	≤	c	|	T	>	t)	
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For	fixed	specificityD(c|t)	=	1	-	p,	the	time-dependent	ROC	value	is	the	corresponding	value	of	sensitivityI(c|t),	or	ROCtI/D(p).	The	time-dependent	AUC	can	be	defined	as	the	area	under	the	time-specific	ROC	curve	across	all	thresholds	p:	AUCI/D(t)	=	ò	ROCtI/D(p)	dp	which	can	be	shown	to	be	equivalent	to	AUCI/D(t)	=	P(Mj	>	Mk	|	Tj	=	t,	Tk	>	t).	Here,	AUCI/D(t)	is	the	probability	that	a	random	subject	j	who	experiences	an	event	at	time	t	(case)	has	a	larger	marker	value	than	a	random	subject	k	who	remains	event-free	through	time	t	(control),	assuming	both	subjects	are	event-free	up	to	time	t.	A	semiparametric	method	based	on	the	Cox	model33,	as	well	as	a	nonparametric	rank-based	method34,	have	been	proposed	for	estimating	ROCtI/D(p)	and	AUCI/D(t)	with	censored	outcomes.	Both	methods	estimate	FPFtD	nonparametrically;	the	difference	comes	from	their	estimation	of	TPFtI,	which	requires	smoothing	since	the	observed	subset	with	
Ti=t	may	only	contain	one	observation.	The	semiparametric	method	achieves	smoothing	by	fitting	a	hazard	model,	whereas	the	nonparametric	method	uses	kernel-based	smoothing	(See	Appendix	A	for	additional	details).	The	nonparametric	approach	is	generally	preferable	as	it	relies	on	fewer	assumptions	than	the	semiparametric	approach.	Additionally,	the	nonparametric	method	has	been	developed	to	provide	a	simple	summary	curve	that	graphically	characterizes	accuracy	over	time.		Furthermore,	the	performance	of	updated	prognostic	information	can	also	be	evaluated	by	using	the	semiparametric33	or	nonparametric34	approach	to	accommodate	time-varying	markers.35	At	any	time	t,	the	last	measured	information	may	be	used	to	obtain	updated	risk	predictions	from	the	prognostic	model,	as	discussed	in	the	previous	section.			
3.2.1	Global	Summary	of	Marker	Performance		In	many	applications,	there	is	no	specific	time	t	of	interest,	and	a	global	accuracy	summary	of	time-varying	performance	is	desired.	Furthermore,	it	may	also	be	of	interest	to	compare	the	overall	performance	of	different	markers	or	models.	The	incident/dynamic	approach	lends	itself	easily	to	addressing	such	questions,	since	marker	performance	can	be	
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summarized	into	a	single-number	global	summary	called	the	survival	concordance	index	(c-index)33:	 c-index	=	P(Mj	>	Mk	|	Tj	<	Tk).	The	c-index	is	interpreted	as	the	probability	that	the	predictions	for	a	random	pair	of	subjects	are	concordant	with	their	outcomes.	In	other	words,	it	is	the	probability	that	the	subject	who	died	at	an	earlier	time	had	a	larger	marker	value.	The	c-index	can	also	be	expressed	as	a	weighted	average	of	time-specific	AUCs33	and	is	therefore	easy	to	estimate	using	the	incident/dynamic	methods	described	above.	The	above	definition	of	the	basic	c-index	for	survival	outcomes	applies	to	a	baseline	marker	M.	However,	the	definition	and	associated	estimation	methods	can	easily	be	generalized	to	accommodate	updated	prognostic	information	to	estimate	the	generalized	c-index	for	a	time-varying	marker,	M(t),	expressed	as:	 generalized	c-index	=	ò	AUCI/D(t)	w(t)	dt	using	the	weighted	average	representation	which	allows	time-varying	markers	to	be	use	for	each	AUCI/D(t)	(See	Appendix	A	for	definition	of	w(t)	with	further	details,	and	Section	4	for	an	illustration).			 	
	
3.3	Extension	to	competing	risk	outcomes	Often	a	subject’s	event	time	can	be	classified	by	one	of	several	distinct	causes	and	interest	may	lie	in	events	of	a	specific	type.	For	example,	in	breast	cancer	studies,	distant	metastasis	may	be	the	event	of	interest;	however,	other	clinical	events,	such	as	death,	may	preclude	the	researcher	from	observing	distant	metastases	for	particular	patients.36	The	definitions	of	time-dependent	sensitivity,	specificity,	ROC	and	AUC	presented	in	Sections	3.1	and	3.2	have	been	extended	to	incorporate	cause	of	failure	for	competing	risk	outcomes	for	both	the	cumulative	and	incident	case	definitions	and	we	direct	the	reader	to	the	associated	literature.37		
	
3.4	Software		
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The	above	methods	have	been	implemented	in	publicly	available	R	statistical	software	packages	survivalROC	(for	cumulative/dynamic	methods),	risksetROC	(for	incident/dynamic	methods	with	semiparametric	estimation)	and	meanrankROC	(for	incident/dynamic	methods	with	nonparametric	estimation).	The	cumulative/dynamic	methods	have	also	been	implemented	as	part	of	the	PHREG	procedure	in	the	commercial	software	SAS.	These	software	options	are	summarized	in	Table	1.	Additionally,	the	
survivalROC	and	risksetROC	packages	have	been	extended	to	include	updated	definitions	for	competing	risk	outcomes.			 We	note	that	the	choice	of	R	package	should	depend	on	the	chosen	method,	which	should	depend	on	the	scientific	question	of	interest,	as	discussed	in	Section	3.5	and	illustrated	using	the	survivalROC	and	meanrankROC	packages	in	the	case	study	of	Section	4	(with	accompanying	code	in	Appendix	B).	
	
3.5	Comparison	of	Cumulative	versus	Incident	Case	Approaches	Use	of	incident	events	naturally	facilitates	evaluation	of	time-varying	prognostic	performance,	whereas	the	use	of	cumulative	events	in	a	sequential	manner	can	also	enable	such	evaluation.	In	practice,	patterns	in	AUCI/D(t)	tend	to	match	AUCC/D(t,t+1)	closely	when	the	gap	between	t	and	t+1	is	small,	although	AUCC/D(t,t+1)	uses	a	coarser	time	scale	and	averages	the	performance	over	a	fixed	time	interval.	In	a	descriptive	context,	AUCI/D	may	be	preferable	because	it	provides	a	simple	graphical	approach	and	a	global	summary	using	the	c-index,	without	having	to	specify	a	time	interval	over	which	cases	accumulate.	In	contrast,	sequential	use	of	cumulative	cases	based	on	AUCC/D	may	better	align	with	clinical	settings	where	prediction	of	short-term	survival	is	needed	at	a	specific	decision	time	(or	a	small	collection	of	times).	For	example,	time	intervals	of	6	months,	1	year	and	5	years	are	commonly	used	for	defining	high-risk	versus	low-risk	patients	for	targeted	intervention.	Methods	for	meaningfully	averaging	time-varying	performance	into	a	global	performance	summary	using	the	cumulative	case	definition	have	not	been	developed.		 Computationally,	AUCI/D(t)	is	more	straightforward	to	estimate	and	visualize	for	a	series	of	time	points.	AUCC/D(t)	requires	the	generation	of	a	new	subsetted	dataset	for	each	
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time	point	of	interest	and	therefore	if	interest	lies	in	several	time	points,	then	a	series	of	AUCC/D(t)	estimates	may	be	more	cumbersome	to	obtain.	
	
4	Case	study:	Liver	Prognostic	Model	to	Guide	Transplantation	in	
Primary	Biliary	Cirrhosis	
	
4.1	Description	of	Study	Cohort		 	The	study	cohort	consisted	of	312	patients;	125	(40%)	of	these	patients	were	observed	to	die	during	the	study	period;	19	subjects	were	recipients	of	liver	transplantation	during	the	study	period.	We	censored	these	subjects	at	the	time	of	transplantation,	since	the	prognostic	model	is	intended	to	predict	the	risk	of	mortality	without	transplantation	and	use	that	risk	to	prioritize	such	patients.	For	each	patient,	we	had	baseline	demographic	and	diagnosis	data	and	longitudinal	data	on	laboratory	measures.	Counting	multiple	observations	per	patient,	we	included	1,945	total	records.		
	
4.2	Risk	models	We	evaluated	the	following	models:	(i)	a	5-covariate	model	containing	the	same	variables	as	those	in	the	Mayo	model1:	log(bilirubin),	albumin,	log(prothrombin	time),	edema	and	age,	and	(ii)	a	4-covariate	model	where	we	omitted	log(bilirubin)	to	illustrate	the	comparison	of	different	candidate	models.	Predictions	from	Cox	models	were	summarized	into	a	single	baseline	risk	score	and	a	separate	time-varying,	updated	risk	score,	in	order	to	demonstrate	that	the	methods	can	incorporate	time-varying	measurements	and	to	show	the	implications	of	using	older	measurements	on	accuracy.	For	the	baseline	score,	we	used	10-fold	cross-validation	to	protect	against	overfitting.15-17	For	the	time-varying	score,	we	used	baseline	measurements	as	training	data	to	develop	the	Cox	model	and	predicted	the	score	at	follow-up	times	using	updated	values	of	log(bilirurbin),	albumin,	and	log(prothrombin	time).15-17		
4.3	What	is	the	accuracy	of	baseline	measurements	and	the	value	of	updated	
measurements?	
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As	a	first	step,	we	use	the	incident/dynamic	approach	to	assess	the	prognostic	accuracy	of	the	baseline	risk	score	obtained	from	the	4-covariate	model	versus	the	5-covariate	model.	Figure	2	and	Table	3	show	that	the	5-covariate	model	has	consistently	better	performance	than	the	4-covariate	model	over	time	with	respect	to	both	AUCI/D(t)	(Table	3	and	Figure	2,	left	panel)	and	sensitivity	for	a	fixed	specificity	of	10%	(Figure	2,	right	panel).	The	estimated	c-indices	are	0.72	(95%	CI:	(0.66,	0.76))	and	0.79	(95%	CI:	(0.75,	0.83))	for	the	4-	and	5-covariate	models,	respectively,	with	a	statistically	significant	difference	of	0.07	(95%	CI:	(0.04,	0.11)).	Table	3	also	shows	the	sequential	cumulative/dynamic	approach	that	uses	successive	1-year	windows	to	define	cases.	We	see	similar	estimates	for	AUCI/D	and	AUCC/D.	Any	observed	differences	are	due	to	AUCI/D	reflecting	performance	at	a	given	time	point	and	AUCC/D	averaging	performance	over	a	1-year	window.		Looking	at	the	5-covariate	model,	the	performance	of	the	baseline	score	declines	over	time	with	AUCI/D	=	0.88	(95%	CI:	(80,	0.90))	at	1	year	versus	0.66	(95%	CI:	(0.62,	0.78))	at	6	years.	In	contrast,	fairly	consistent	performance	is	maintained	using	a	risk	score	that	is	updated	over	time	(AUCI/D(t)	=	0.92	(95%	CI:	(0.88,	0.96))	at	1	year,	0.89	(95%	CI:	(0.84,	0.92))	at	6	years)	(Table	3	and	Figure	3).	95%	confidence	intervals	are	included	in	Table	3,	and	can	also	be	included	in	plots,	as	shown	in	Figure	4	for	baseline	and	updated	risk	scores	from	the	5-covariate	model.	Similar	patterns	are	observed	for	the	4-covariate	model,	with	the	baseline	score’s	performance	declining	over	time	and	the	updated	risk	score’s	performance	staying	fairly	steady.	Interestingly,	the	updated	4-covariate	risk	score	performs	almost	as	well	as	the	updated	5-covariate	risk	score,	indicating	that	some	of	the	loss	of	accuracy	due	to	the	omission	of	log(bilirubin)	can	be	recovered	by	using	updated	measurements	on	other	variables.		
4.4	Implications	for	Decision-Making	in	PBC	This	Mayo	risk	score	has	been	used	for	individual-level	decision-making	about	transplantation	over	time,	by	selecting	patients	who	are	most	likely	to	die	in	a	short	time	interval	from	the	time	of	prediction.	We	used	the	five	main	predictors	of	survival	identified	by	Dickson	et	al.1	to	calculate	the	predicted	risk	of	mortality	and	evaluate	the	accuracy	of	these	predictions	toward	prioritizing	patients	for	transplantation.	It	is	clear	from	the	
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results	that	patient	information	should	be	updated	regularly	in	practice,	in	order	to	maintain	prognostic	accuracy.	The	updated	5-covariate	Mayo	model	maintains	an	AUCI/D	of	around	0.90	over	time,	with	a	high	generalized	c-index	of	0.89	(95%	CI:	(0.84,	0.92)),	indicating	that	it	is	a	strong	prognostic	model	for	use	in	practice.		Additionally,	we	used	AUCC/D	sequentially	with	1-year	windows	to	evaluate	the	use	of	the	Mayo	model	as	a	decision-making	tool	in	practice.	We	found	that	AUCC/D	is	consistently	above	0.80	at	all	chosen	time	points,	indicating	that	the	model	identifies	high-risk	patients	for	transplantation	with	good	accuracy.		
5	Discussion	The	American	Heart	Association’s	2009	criteria	for	evaluating	a	risk	prediction	model	categorize	performance	measures	into	those	of	calibration,	association,	discrimination,	and	risk	reclassification.38	Similarly,	Steyerberg	et	al39	differentiated	the	roles	of	various	performance	measures	for	assessing	prediction	models,	defining	them	as	measures	of	overall	performance,	discrimination,	calibration,	reclassification,	and	clinical	usefulness.	They	explained	that	these	measures	serve	different	purposes	and	suggested	that	“reporting	discrimination	and	calibration	will	always	be	important	for	a	prediction	model”.	Although	their	focus	was	on	binary	outcomes,	the	same	ideas	hold	for	survival	outcomes.		In	this	tutorial,	we	focused	on	discrimination	accuracy	(other	work	has	demonstrated	calibration	for	prognostic	models	for	survival	outcomes40).	We	presented	methods	that	extend	standard	diagnostic	definitions	of	sensitivity	and	specificity	and	develop	key	summaries	for	evaluating	the	time-varying	prognostic	performance	of	a	marker	or	model	measured	at	baseline	only	or	updated	in	routine	clinical	care.	A	basic	epidemiologic	concept	that	distinguishes	alternative	summaries	is	the	idea	of	cumulative	versus	incident	events	to	define	cases.	AUCI/D(t)	is	a	convenient	descriptive	and	graphical	summary	that	characterizes	time-varying	performance	without	having	to	select	a	particular	timeframe	over	which	cases	accrue,	whereas	sequential	use	of	AUCC/D(t)	may	be	useful	in	clinical	settings	where	predictions	of	short-term	survival	are	needed	at	select	times	to	identify	high-risk	patients	for	targeted	intervention.		
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	 In	addition	to	allowing	for	evaluation	of	time-varying	discrimination	accuracy	of	prognostic	models,	there	are	other	implications	for	how	these	methods	could	be	applied	in	practice.	First,	these	methods	may	guide	practice	and	policy	with	regards	to	the	frequency	of	updating	patient	information,	by	comparing	the	performance	of	risk	scores	updated	using	different	measurement	schedules	to	assess	how	often	patient	information	should	be	updated	before	it	becomes	outdated	and	impacts	accuracy.	Second,	although	we	compared	the	5-covariate	Mayo	model	to	a	simple	4-covariate	variation	of	the	model	for	illustration,	in	practice,	one	may	choose	more	clinically	relevant	variables,	such	as	more	expensive	measures,	to	omit	or	replace	and	assess	the	impact	on	prognostic	accuracy.	Finally,	one	may	choose	to	explore	the	performance	of	a	risk	model	in	subsets	of	patients,	say	older	versus	younger	patients,	to	assess	whether	the	model	is	a	better	decision-making	tool	for	particular	subgroups.	One	limitation	of	this	tutorial	is	that	we	do	not	discuss	model	selection	in	detail,	focusing	on	the	evaluation	of	a	given	model.	However,	the	methods	for	model	evaluation	that	we	discuss	could	also	be	used	at	the	stage	of	model	selection	to	guide	identification	of	a	model	with	optimal	performance.	For	example,	with	variable	selection	in	high-dimensional	settings,	one	may	use	the	c-index,	which	is	a	global	summary	of	time-varying	performance,	as	a	way	of	initially	screening	the	strongest	markers	as	candidates	for	combining	into	a	multivariate	risk	score.	One	may	also	use	the	c-index	as	the	optimization	criterion	in	model	selection,	instead	of	the	typically	used	likelihood-based	criteria.41-43	For	example,	approaches	that	optimize	the	c-index	have	been	developed	using	boosting.44,45	A	potential	limitation	of	the	case	study	is	that	in	the	absence	of	an	independent	dataset	on	PBC,	our	illustration	of	methods	for	evaluation	uses	the	same	dataset	that	was	used	by	Dickson	et	al1	to	develop	the	Mayo	model.	As	discussed	in	Section	1.2,	the	standard	approach	is	to	use	separate	training	and	validation	datasets	to	fairly	assess	model	performance.	We	used	cross-validation	to	mitigate	the	potential	issue	of	an	optimistic	assessment.	In	practice,	an	independent	validation	dataset	is	important	if	the	results	may	have	clinical	implications.	However,	this	case	study	was	meant	to	illustrate	methods,	rather	than	inform	clinical	practice.	Additionally,	the	case	study	uses	data	from	a	trial	conducted	between	1974	and	1984.	Again,	a	newer	dataset	would	not	add	substantially	to	our	
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primary	goal	of	illustrating	methods.	Furthermore,	the	Mayo	model,	which	is	widely	used	in	practice	today,	was	developed	using	the	same	dataset.	Finally,	there	is	growing	interest	in	evaluating	the	incremental	value	gained	from	adding	a	new	marker(s)	to	an	existing	baseline	marker	or	model.	Difference	in	AUC	is	a	popular	metric	for	evaluating	incremental	value.	As	we	illustrated	using	the	case	study,	the	time-varying	incremental	value	of	a	marker	can	be	evaluated	by	comparing	the	time-varying	AUCs	of	two	models.		Additionally,	a	number	of	alternative	measures	have	been	proposed	in	recent	literature	for	binary	outcomes,	namely	the	net	reclassification	index46	and	integrated	discrimination	improvement47.	Extensions	of	these	measures	for	time-dependent	outcomes	have	been	developed48,49	and	can	provide	alternative	summaries	of	the	time-varying	incremental	value	of	a	marker.			
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Tables	 Table	1:	A	guide	to	available	software	for	conducting	analyses	using	the	cumulative/dynamic	and	incident/dynamic	methods		
Measures	of	Interest	 Software	
Cumulative	
cases/Dynamic	controls	
R	package	survivalROC	
• ROC	function	 survivalROC.C()	accepts	censored	survival	data	and	returns	a	set	of	TPF	and	FPF	values	for	construction	of	the	ROC	curve,	ROCs,tC/D,	where	s	is	the	“baseline”	time	of	the	subsetted	dataset,	i.e.	T	≥	s,	while	t	(specified	using	the	
predict.time	argument)	defines	the	window	over	which	cases	accumulate,	so	that	T	≤	t	defines	cases	and	T	>	t	defines	controls.	The	function	calculates	estimates	and	associated	95%	confidence	intervals	for	ROCs,tC/D(p)	on	subsetted	datasets	based	on	new	index	(or	“baseline”)	times	and	updated	marker	values.	
• AUC	function	 survivalROC.C()	(described	above)	also	calculates	estimates	and	associated	95%	confidence	intervals	for	AUCC/D(s,t).	
• Example	 The	documentation	for	the	survivalROC	package	demonstrates	the	above	functionality	on	baseline	markers	in	the	Mayo	PBC	dataset.	Furthermore,	see	Section	4	of	this	tutorial	(and	Appendix	B	for	corresponding	R	code)	for	an	illustration	of	the	package	applied	to	assessing	time-
dependent	discrimination	accuracy	of	both	baseline	and	
time-varying	markers. 
Cumulative	
cases/Dynamic	controls	
SAS procedure PHREG 
• ROC	function	 The	PHREG	procedure	accepts	censored	survival	data	and	allows	construction	of	the	ROC	curve,	ROCs,tC/D,	where	s	is	
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the	“baseline”	time	of	a	subsetted	dataset,	i.e.	T	≥	s.	One	can	specify	AT=t	in	the	ROCOPTIONS	in	the	PROC	PHREG	statement,	in	order	to	define	the	window	over	which	cases	accumulate,	so	that	T	≤	t	defines	cases	and	T	>	t	defines	controls.	Specifying	PLOTS=ROC	in	the	PROC	PHREG	statement	displays	the	ROC	curve	at	selected	time	points. 
• AUC	function	 Using	the	same	options	as	above,	but	instead	specifying	
PLOTS=AUC	in	the	PROC	PHREG	statement	displays	the	AUC	and	the	95%	confidence	limits	with	respect	to	time.	
• Example	 The	SAS	User’s	Guide	for	the	PHREG	procedure	demonstrates	the	above	functionality	on	the	Mayo	PBC	dataset	to	assess	time-varying	performance	and	to	compare	models.	
Incident	cases/Dynamic	
controls	(Semiparametric	
estimation)	
R	package	risksetROC	
• ROC	function	 risksetROC()calculates	estimates	and	associated	95%	confidence	intervals	for	ROCtI/D(p)	by	accommodating	updated	marker	values	by	using	time-dependent	data	and	appropriately	specifying	the	entry	and	Stime	arguments.	For	example,	consider	the	illustrative	dataset	in	Table	2(a)	with	marker	values	measured	only	at	baseline.	Compare	this	to	the	time-dependent	dataset	in	Table	2(b)	that	includes	monthly	updated	marker	values.	When	a	new	marker	value	is	available,	the	individual	is	censored	with	the	old	value	and	re-enters	the	study	with	the	new	value	at	the	updated	entry	time.	
• AUC	function	 risksetROC()(described	above)	also	calculates	estimates	and	associated	95%	confidence	intervals	for	AUCI/D(t).	
• c-index	function	 risksetAUC()estimates	the	c-index.	Confidence	intervals	
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can	be	computed	using	bootstrapping,	as	illustrated	in	the	annotated	code	of	Appendix	B.	
• Example	 The	documentation	for	the	riskROC	package	demonstrates	the	above	functionality	on	a	lung	cancer	dataset	(also	freely	available	in	R,	like	the	Mayo	PBC	dataset).	 
Incident	cases/Dynamic	
controls	(Nonparametric	
estimation)	
R	package	meanrankROC	
ROC	function	 dynamicTP()	accommodates	updated	marker	values	by	using	time-dependent	data	as	above,	and	appropriately	specifying	start	and	stop	times	for	intervals	with	updated	marker	values.	dynamicTP(),	along	with	
nne_TPR()	provides	a	smooth	curve	over	time	of	sensitivity	(or	TPF)	or	ROCtI/D(p)	for	a	fixed	specificity	1-p. AUC	function	 MeanRank()	accommodates	updated	marker	values	by	using	time-dependent	data	as	above,	and	appropriately	specifying	start	and	stop	times	for	intervals	with	updated	marker	values.	MeanRank(),	along	with	
nne.Crossvalidate()	provides	a	smooth	curve	of	AUCI/D(t)	over	time.	c-index	function	 dynamicIntegrateAUC()estimates	the	c-index.	Confidence	intervals	can	be	computed	using	bootstrapping,	as	illustrated	in	the	annotated	code	of	Appendix	B.	Example	 See	Section	4	of	this	tutorial	(and	Appendix	B	for	corresponding	R	code)	for	an	illustration	of	the	
meanrankROC	package	applied	to	assessing	time-dependent	discrimination	accuracy	of	both	baseline	and	time-varying	markers. 		
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Table	2:	An	illustration	of	datasets	with	marker	values	(a)	measured	only	at	baseline	and	(b)	updated	approximately	every	month.		Subjects	are	censored	when	a	new	marker	value	is	available,	and	they	re-enter	the	study	with	the	new	marker	value	and	an	updated	start	time.		(a)	Marker	measured	at	baseline	only	Subject	 Marker	 Start	time	(days)	 Stop	time	(days)	 Death	observed	1	 m0	 0	 65	 1	2	 m0	 0	 40	 0		(b)	Marker	measured	approximately	monthly	Subject	 Marker	 Start	time	(days)	 Stop	time	(days)	 Death	observed	1	 m0	 0	 25	 0	1	 m25	 25	 58	 0	1	 m58	 58	 65	 1	2	 m0	 0	 30	 0	2	 m30	 30	 40	 0		
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	Table	3:	Time-varying	performance	of	baseline	and	updated	risk	scores	from	the	4-covariate	and	5-covariate	models	using	AUCI/D	and	AUCC/D	mimicking	landmark	analysis			 AUCI/D(t)	(95%	CI)	 c-index	(95%	CI)	 AUCC/D(t,	t+1	year)		(95%	CI)	t	=	1	year	 t	=	4	years	 t	=	6	years	 t	=	1	year	 t	=	4	years	 t	=	6	years	Baseline	risk	scores	4-covariate	model	 0.84	(0.79,	0.89)	 0.69	(0.60,	0.76)	 0.64	(0.55,	0.70)	 0.72	(0.66,	0.74)	 0.77	(0.56,	0.95)	 0.72	(0.55,	0.87)	 0.77	(0.60,	0.88)	5-covariate	model	 0.88	(0.80,	0.91)	 0.85	(0.74,	0.86)	 0.66	(0.62,	0.78)	 0.79	(0.76,	0.83)	 0.80	(0.57,	0.93)	 0.78	(0.66,	0.91)	 0.65	(0.44,	0.89)	Updated	risk	scores	4-covariate	model	 0.90		(0.86,	0.96)	 0.86		(0.80,	0.91)	 0.84		(0.77,	0.90)	 0.86	(0.80,	0.89)	 0.79	(0.61,	0.95)	 0.81	(0.63,	0.91)	 0.84		(0.63,	0.95)	5-covariate	model	 0.92		(0.88,	0.96)	 0.92		(0.86,	0.95)	 0.88		(0.82,	0.93)	 0.89	(0.84,	0.92)	 0.82		(0.70,	0.94)	 0.84		(0.68,	0.94)	 0.87		(0.66,	0.99)		
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Figure	Legends	Figure	1:	An	illustration	of	assessments	at	sequential	baseline	time	points.	Solid	circles	represent	events	and	hollow	circles	represent	censored	subjects.	At	each	starting	time	point,	subjects	that	remain	event-free	are	used	for	analysis.	The	solid	red	vertical	line	represents	this	cut-off.	The	dashed	blue	vertical	line	represents	the	subsequent	1-year	cut-off	which	is	used	to	define	cases	versus	controls.			Figure	2:	Time-varying	prognostic	accuracy	of	baseline	risk	scores	obtained	from	the	4-covariate	model	versus	the	5-covariate	model	over	time	using	the	incident/dynamic	approach,	with	respect	to	(a)	AUCI/D(t)	and	(b)	ROCtI/D	for	a	fixed	false	positive	fraction	(FPF)	of	10%	(or	sensitivity	for	a	fixed	specificity	of	90%).		Figure	3:	Time-varying	prognostic	accuracy	of	updated	risk	scores	obtained	from	the	4-covariate	model	versus	the	5-covariate	model	over	time	using	the	incident/dynamic	approach,	with	respect	to	(a)	AUCI/D(t)	and	(b)	ROCtI/D	for	a	fixed	false	positive	fraction	(FPF)	of	10%	(or	sensitivity	for	a	fixed	specificity	of	90%).		Figure	4:	Time-varying	prognostic	accuracy	with	95%	confidence	intervals	of	(a)	baseline	and	(b)	updated	risk	scores	obtained	from	the	5-covariate	model	using	the	incident/dynamic	approach.	
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Figure	3	 	(a)	 	 	 	 	 	 (b)	
	Figure	4	 	(a)	 	 	 	 	 	 (b)	
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Appendix	A:	Estimation	Methods	Let		
• M	denote	a	continuous	marker	or	test.	By	convention,	higher	values	of	M	are	more	indicative	of	the	adverse	outcome	
• T	denote	the	failure	time	
• C	denote	the	censoring	time	
• Z	=	min(T,	C)	is	the	follow-up	time	
• d		denote	the	event	indicator	with	d	=	1	if	T	£	C	and	d	=	0	if	T	>	C	
• subscript	i	denote	the	variables	for	a	subject	i		
1.	Cumulative	(Prevalent)	Cases	/	Dynamic	Controls	Let	
• s	denote	the	start	time	of	case	ascertainment	(often	s=0	for	baseline)	
• t	denote	the	stop	time	of	case	ascertainment	At	any	give	times	s	and	t	and	given	cut-off	value	c,	we	define	sensitivity	and	specificity	as:	SeC(c	|	start	=	s,	stop	=	t)	=	P(M	>	c	|	T	≥	s	,	T	≤	t)		SpD(c	|	start	=	s,	stop	=	t)	=	P(M	≤	c	|	T	≥	s	,	T	>	t)		Using	these	definitions,	the	corresponding	ROC	curve	can	be	defined	at	any	times	s,	t.	Heagerty	et	al.1	developed	two	estimators	for	sensitivity	and	specificity	where	case	ascertainment	was	assumed	to	begin	at	baseline,	i.e.	s	=	0.	These	methods,	described	below,	can	be	extended	to	sequential	baseline	values	of	s	to	characterize	time-varying	performance,	as	described	in	the	main	text.	
	
(a)	Kaplan-Meier	estimator	Using	Bayes’	Theorem,	the	widely	used	nonparametric	Kaplan-Meier	estimate	of	the	survival	function,	and	the	empirical	distribution	function	of	the	marker	M,	Heagerty	et	al.1	provided	simple	estimators	for	sensitivity	and	specificity	as	Se#$(c|start = 0, stop = 1) = 	 41 − 789:(1|; > =)>	{1 − @A:(=)}1 − 789:(1) 	
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Sp#C(c|start = 	0, stop = 1) = 	789:(1|; ≤ =)		@A:(=)789:(1) 	where	789:(1)	is	the	Kaplan-Meier	estimate	of		the	survival	function,	789:(1|; > =)	is	the		Kaplan-Meier	estimate	of	the	conditional	survival	function	for	the	subset	defined	by	M	>	c,	and	@A:(=) = 	 EF ∑ 1(;H ≤ =)	is	the	empirical	distribution	function	of	the	marker	M.	The	Kaplan-Meier	estimator	is	a	standard	and	widely-used	nonparametric	estimator	of	the	survival	function,	which	uses	all	the	information	in	the	data,	including	censored	observations,	for	estimation.	However,	there	are	two	potential	drawbacks	of	this	estimation	approach:	(i)	it	does	not	guarantee	that	sensitivity	and	specificity	are	monotone	in	M	and	bounded	by	[0,1],	and	(ii)	the	conditional	Kaplan-Meier	estimator	789:(1|; > =)	assumes	that	the	censoring	mechanism	does	not	depend	on	M.	This	assumption	may	be	violated	in	practice	when	the	intensity	of	follow-up	is	influenced	by	the	marker	measurements,	a	common	scenario	that	results	in	marker-dependent	censoring.			
(b)	Nearest	neighbor	estimator	An	alternative	approach	proposed	by	Heagerty	et	al.1	to	address	the	above	drawbacks	is	based	on	a	nearest	neighbor	estimator	for	the	bivariate	distribution	function	of	(M,	T),	
F(c,t)	=	P(M	≤	c,	T	≤	t),	or	equivalently,	S(c,t)	=	P(M	>	c,	T	>	t),	that	was	provided	by	Akritas2.	The	estimator	is	based	on	the	representation:	S(c,t)	=	∫ 7(1|; = J)K@:LM (J),	where	FM(s)	is	the	distribution	function	of	M.	This	estimator	is	provided	by	78NO(=, 1) = 	 EF ∑ 78NOH (1|; = ;H)1(;H > =),	where	78NO(1|; = ;H)	is	a	suitable	estimator	of	the	conditional	survival	function	characterized	by	a	smoothing	parameter	λn.	Unless	M	is	discrete	and	there	are	sufficient	observations	at	each	value	of	M,	some	smoothing	is	required	to	estimate	S(t	|	M	=	Mi).	PNOQ;R,;HS	is	defined	as	a	kernel	function	that	depends	on	a	smoothing	parameter	λn.	Using	the	kernel	function,	a	weighted	Kaplan-Meier	estimator	follows:	78NO(1|; = ;H) = 	 T U1−	∑ PNOQ;R,;HSR 1(VR = J)WR∑ PNOQ;R,;HSR 1(VR = J) XYZ[O,Y\] 	where	[F	is	the	set	of	unique	values	of	Zi	for	observed	events,	WH = 1.	
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Akritas2	used	a	0/1	nearest	neighbor	kernel,	PNOQ;R,;HS = 14−^F < @A:(;H) −	@A:Q;RS < ^F>,	where	2λn	∈		(0,	1)	represents	the	percentage	of	individuals	that	are	included	in	each	neighborhood.	The	resulting	estimates	of	sensitivity	and	specificity	are	given	by	 Se#$(c|start = 0, stop = 1) = 	 41 − @A` (=)> − 78NO(=, 1)1 − 78NO(1) 	Sp#C(c|start = 	0, stop = 1) = 	1 − 78NO(=, 1)78NO(1) 	where	78NO(1) = 78NO(−∞, 1).	These	estimates	allow	for	monotonicity	of	the	sensitivity	and	specificity.	Furthermore,	since	only	local	Kaplan-Meier	estimators	are	used	in	each	possible	neighborhood	of	M=m,	the	censoring	process	is	allowed	to	depend	on	the	marker	M.		
	
2.	Incident	Cases	/	Dynamic	Controls	At	any	give	time	t	and	given	cut-off	value	c,	incident	sensitivity	and	dynamic	specificity	are	defined	by	dichotomizing	the	risk	set	at	time	t	into	those	observed	to	die	(cases)	and	those	observed	to	survive	(controls):	 SeI(c	|	t)	=	P(M	>	c	|	T	=	t)	SpD(c	|	t)	=	P(M	≤	c	|	T	>	t)	Using	these	definitions,	the	corresponding	ROC	curve	can	be	defined	at	any	time	t.	Below	we	describe	two	estimators	for	sensitivity	and	specificity	based	on	the	incident/dynamic	definition.		
(a)	Semi-parametric	Cox	model	based	estimator	Heagerty	&	Zheng3	proposed	Cox	model	based	methods	that	use	riskset	reweighting	based	on	the	estimated	hazard	in	order	to	estimate	sensitivity	and	specificity.	The	censoring	time	is	assumed	to	be	independent	of	the	failure	time	and	marker.	Under	proportional	hazards,	a	standard	Cox	model	is	fit:	
λ(t	|	Mi)	=	λ0(t)	exp(Mi	b)	To	estimate	sensitivity	and	specificity,	i.e.	the	marker	distribution	conditional	on	survival	time,	Heagerty	&	Zheng3	use	Xu	and	O’Quigley’s	result	that	partial	likelihood	estimation	
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methods	can	be	exploited	to	provide	model-based	estimates	of	the	distribution	of	covariates	conditional	on	survival	time.3,4	Specifically,	letting	Ri(t)	=	1(Mi	≥	t)	denote	the	at-risk	indicator,		cH(b, 1) = 	 de(])	fgh	(:ei)∑ dj(])	fgh	(:ji)j 		can	be	used	to	estimate	the	distribution	of	marker	
M	,	conditional	on	the	event	occurring	at	time	t,	so	that	kA(;H ≤ l	|	mH = 1) =	∑ cn(bo, 1)n 	1(;n ≤ l).	This	result	and	using	partial	likelihood	to	estimate	b	directly	give	a	semiparametric	estimator	of	sensitivity,	which	uses	a	reweighting	of	the	marker	distribution	observed	among	the	riskset	at	a	time	t:	Se#p(c	|	1) = 	kA(; > =	|	m = 1) = 	q1(;n > =)n 	cn(bo, 1)	The	methods	can	also	accommodate	non-proportional	hazards.	A	varying-coefficient	model	of	the	form	λ(t	|	Mi)	=	λ0(t)	exp(Mi	b(1))	can	be	fit	to	obtain	the	time-varying	coefficient	bo(1)	and	estimate	sensitivity	as:	Se#p(c	|	1) = 	kA(;H > =	|	mH = 1) = 	q1(;n > =)n 	cn[bo(1), 1]	The	time-varying	coefficient,	b(1),	and	subsequently	AUCI/D(t),	can	be	estimated	using	flexible	semiparametric	locally	weighted	partial	likelihood	methods5	or	local	linear	smoothing	of	the	scaled	Schoenfeld	residuals.	An	empirical	estimator	of	specificity	is	given	as:	Sp#C(c	|	1) = 	kA(; ≤ =	|	m > 1) = 	∑ 1(;n > =, mn > 1)n ∑ 1(mn > 1)n 	
	
(b)	Non-parametric	rank-based	estimator	A	nonparametric	rank-based	approach	for	the	estimation	of	AUCI/D(t)	was	proposed	by	Saha-Chaudhuri	&	Heagerty6.	For	a	fixed	time	t,	a	percentile	is	calculated	for	each	case	in	the	risk	set	relative	to	the	controls	in	the	risk	set.	A	perfect	marker	would	have	the	case	marker	value	greater	than	100%	of	risk	set	controls.	The	mean	percentile	at	time	t	is	calculated	as	the	mean	of	the	percentiles	for	all	cases	at	t,	as	follows:	t(1) = 1u]K] 	q q 1(;H > ;R)RZℛwxHZℛwy 	where	ℛ]E	and	ℛ]z	denote	the	sets	of	cases	and	controls	in	the	risk	set	at	time	t,	respectively.	
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Unless	there	are	sufficient	events	at	each	time	t,	some	smoothing	is	typically	required	to	estimate	the	AUC.	Using	a	standardized	kernel	function	such	that	∑ P{OQ1 −R1RS = 1	based	on	a	neighborhood	of	points	defined	by	parameter	ℎF,	Saha-Chaudhuri	&	Heagerty6	defined	a	smoothed	estimator	of	AUC	by:	t}~(1) = qP{OQ1 − 1RS	tQ1RSR .	They	used	a	nearest	neighbor	kernel,	resulting	in	the	following	weighted	mean	rank	(WMR)	estimator:	 Å;Ç(1) = 1|É](ℎF)|	 q t(1R)]jZÉw({O) 	where	É](ℎF) = (1R: Ö1 − 1RÖ < ℎF)	denotes	a	neighborhood	around	time	t.	This	estimator	is	used	to	estimate	the	summary	curve,	AUCI/D(t),	as	the	local	average	of	mean	case	percentiles.	This	nonparametric	approach	provides	a	simple	description	of	marker	performance	within	each	risk	set	and,	by	smoothing	individual	case	percentiles,	a	final	summary	curve	characterizes	accuracy	over	time.		 A	smooth	curve	of	sensitivity	for	a	fixed	specificity	can	be	estimated	in	a	similar	manner	as:	 Se#p(Sp	|	1) = 	qP{OQ1 − 1RS	1[t(1) > Sp]R 	
	
(c)	The	concordance-index	or	c-index	The	c-index	can	also	be	expressed	as	a	weighted	average	of	the	area	under	time-specific	ROC	curves	(AUCs)3,	obtained	using	the	incident/dynamic	definition	of	sensitivity	and	specificity:	 c-index	=	òt	AUCI/D(t)	w(t)	dt	where	w(t)=2	f(t)	S(t),	f(t)	represents	the	distribution	of	failure	times	T	and	S(t)	represents	the	survival	time.	The	c-index	is	straightforward	to	estimate	using	the	methods	described	above.	Specifically,	AUCI/D(t)	can	be	estimated	using	the	semiparametric	or	nonparametric	approaches	described	in	subsections	(a)	and	(b)	above,	respectively,	and	f(t)	and	S(t)	are	derived	nonparametrically,	using	the	Kaplan-Meier	estimate	of	the	survival	function.	
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3.	Competing	Risk	Outcomes	Here	we	assume	that	a	single	event	time	Ti	may	correspond	to	J	mutually	exclusive	types	or	causes	of	failure,	j	=	1,	2,	…,	J	and	we	may	be	interested	in	one	or	more	specific	types.	We	generalize	the	definition	of	the	event	indicator	WH,	so	that	WH = 1,2,… , à	indicates	a	specific	type	or	cause	of	failure,	while	WH = 0	indicates	censoring	as	before.		
a)	Cumulative	(Prevalent)	Cases	/	Dynamic	Controls	For	the	setting	of	competing	risk	events,	Saha	&	Heagerty7	modified	the	approach	of	Heagerty	et	al1	by	using	nearest	neighbor	estimation	for	the	cumulative	incidence	function	(CIF)	associated	with	each	type	of	failure,	instead	of	the	bivariate	distribution	function	of	the	marker	and	time,	(M,	T).	Estimation	of	sensitivity	is	based	on	the	weighted	conditional	CIF,	estimated	as	follows:		~8R(1|; = ;H) = 	∑ 78∈OYä] (J|; = ;H) 8^R(J|; = ;H),	where	 8^R(J|; = ;H)	is	the	observed	hazard	for	event	type	j	at	time	t	and	78∈O(J|; = ;H)	is	a	locally	weighted	Kaplan-Meier	estimator	of	the	conditional	survival	function,	defined	as	before	using	a	nearest	neighbor	kernel	P∈OQ;R,;HS	that	depends	on	a	smoothing	parameter	∈n,	with	2∈n	∈		(0,	1)	representing	the	percentage	of	individuals	that	are	included	in	each	neighborhood.	Using	the	kernel	function,	a	weighted	Kaplan-Meier	estimator	follows:	78∈O(1|; = ;H) = 	 T U1−	∑ P∈O(;n,;H)n 1(Vn = J)Wn∑ P∈O(;n,;H)n 1(Vn ≥ J) XYZ[O,Y\] 	where	[F	is	the	set	of	unique	observed	event	times	for	the	event	of	interest,	W = å.	The	resulting	estimate	of	sensitivity	for	event	j	is	given	by	Se#$R(c|start = 0, stop = 1) = k(; > =, m ≤ 1, çéçu1	1èêç = å)k(m ≤ 1, çéçu1	1èêç = å) = 	 ∫ ~8RLM (1|; = ë)í8:(ë)Kë∫ ~8RLìL (1|; = ë)í8:(ë)Kë	where	fM(s)	is	the	probability	density	function	of	marker	M.		 To	estimate	specificity,	Saha	&	Heagerty7	also	use	the	CIF	conditional	on	marker	M	to	get:		 Sp#C(c|start = 	0, stop = 1) = 	kA(; > =, m > 1)kA(m > 1) = ∫ kA(m > 1,; = ë)KëLM∫ kA(m > 1,; = ë)KëLìL 	
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																										= 	 ∫ kA(m > 1|; = ë)í8:(ë)KëLM∫ kA(m > 1|; = ë)í8:(ë)KëLìL 																																																										= 	 ∫ [1 −	∑ kA(m ≤ 1, W = å	|	; = l)R ]	í8:(ë)KëLM∫ î1 −	∑ kA(m ≤ 1, W = å	|	; = l)R ï	í8:(ë)KëLìL 																																						= 	 ∫ [1 −	∑ ~8R(1	|	; = l)R ]	í8:(ë)KëLM∫ î1 −	∑ ~8R(1	|	; = l)R ï	í8:(ë)KëLìL 		
b)	Incident	Cases	/	Dynamic	Controls		Saha	&	Heagerty7	showed	that	the	riskset	reweighting	used	by	Heagerty	&	Zheng3	to	estimate	the	sensitivity	k(;H > =	|	mH = 1)	can	also	be	used	with	competing	risks	data.	Under	proportional	hazards,	a	standard	Cox	model	is	fit	for	event	of	type	j:	
λj(t	|	Mi)	=	λ0,j(t)	exp(Mi	bR)	where	bR 	is	the	cause-specific	hazard	for	event	of	type	j	associated	with	the	marker.	bR 	can	be	estimated	using	Maximum	Partial	Likelihood	Estimation	by	censoring	all	other	types	of	failure.	As	before,	letting	Ri(t)	=	1(Mi	≥	t)	denote	the	at-risk	indicator	for	time	t,		cHRQbR, 1S =	 de(])	fgh	(:eij)∑ dñ(])	fgh	(:ñij)ñ 		for	the	event	of	type	j	can	be	used	to	estimate	the	distribution	of	marker	
M,	conditional	on	event	j	occurring	at	time	t,	so	that	the	estimates	of	sensitivity	and	specificity	are	analogous	to	those	presented	by	Heagerty	&	Zheng3.	Specifically,	we	get	the	following	semiparametric	estimator	of	sensitivity	for	event	type	j:	Se#pR(c	|	1) = 	kA(; > =	|	m = 1, event	type = å) = 	∑ 1(;n > =)n 	cnRQboR, 1S.	The	methods	can	also	accommodate	non-proportional	hazards,	by	replacing	boR	with	an	estimate	of	the	time-varying	coefficient,	bR(1),	just	as	before.	The	time-varying	coefficient,	bR(1),	and	subsequently	AUCI/D(t),	can	be	estimated	using	flexible	semiparametric	locally	weighted	partial	likelihood	methods5	or	local	linear	smoothing	of	the	scaled	Schoenfeld	residuals.	An	empirical	estimator	of	specificity	is	given	as	Sp#C(c	|	1) = 	kA(; ≤ =	|	m > 1) = 	∑ 1(;n > =, mn > 1)n ∑ 1(mn > 1)n 	
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Appendix	B:	Annotated	R	code	
library(survival) 
 
install.packages("survivalROC") 
install.packages("risksetROC") 
library(survivalROC) 
library(risksetROC) 
 
#Download meanrankROC package from github: https://github.com/aasthaa/meanrankROC_package 
 
source("MeanRank.q") 
source("NNE-estimate.q") 
source("NNE-CrossValidation.q") 
source("interpolate.q") 
 
source("dynamicTP.q") 
source("NNE-estimate_TPR.q") 
 
source("dynamicIntegrateAUC.R") 
 
#Load in the datasets. Note: The PBC data is freely available in R. 
bDat <- pbc[1:312,] #baseline data 
bDat$deathEver <- bDat$status 
bDat$deathEver[which(bDat$status==1)] <- 0 #censor at transplant 
bDat$deathEver[which(bDat$status==2)] <- 1 #death 
 
#Build dataset with time-dependent covariates 
pbc2 <- tmerge(pbc, pbc, id=id, death = event(time, status)) #set range 
pbc2 <- tmerge(pbc2, pbcseq, id=id, ascites = tdc(day, ascites), hepato = tdc(day, hepato), 
   spiders = tdc(day, spiders), edema = tdc(day, edema), chol = tdc(day, chol),  
   bili = tdc(day, bili), albumin = tdc(day, albumin), 
   protime = tdc(day, protime), alk.phos = tdc(day, alk.phos), 
   ast = tdc(day, ast), platelet = tdc(day, platelet), stage = tdc(day, stage) ) 
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length(unique(pbc2$id)) 
 
dim(pbc2) 
pbc2 <- subset(pbc2, id>=1 & id<=312) 
dim(pbc2) 
length(unique(pbc2$id)) 
dim(bDat) 
 
 
#According to documentation, some baseline values for protime and age in pbc were found to be incorrect. 
Correct values in pbcseq 
bDat[1:5,] 
subset(pbc2, tstart==0)[1:5,] 
for(i in 1:312){ 
   if(pbc2$protime[which(pbc2$id==i & pbc2$tstart==0)] != bDat$protime[i]) 
      pbc2$protime[which(pbc2$id==i & pbc2$tstart==0)] <- bDat$protime[i] 
       
   if(pbc2$age[which(pbc2$id==i & pbc2$tstart==0)] != bDat$age[i]) 
      pbc2$age[which(pbc2$id==i & pbc2$tstart==0)] <- bDat$age[i] 
} 
 
pbc2$deathEver <- pbc2$status 
pbc2$deathEver[which(pbc2$status==1)] <- 0 
pbc2$deathEver[which(pbc2$status==2)] <- 1 
 
pbc2$death[which(pbc2$death==1)] <- 0 
pbc2$death[which(pbc2$death==2)] <- 1 
 
 
 
#Use 10-fold CV to get baseline scores 
set.seed(49) 
 
samples <- floor(runif(nrow(bDat), 1,11)) 
sampSizes <- sapply(seq(1:10), function(s){length(which(samples==s))} ) 
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sampSizes #Check that no subsets with 0 subjects 
 
while(min(sampSizes)==0) { 
   samples <- floor(runif(nTrain, 1,11)) 
   sampSizes <- sapply(seq(1:10), function(s){length(which(samples==s))} ) 
} 
 
###10-fold cross-validation to get predicted baseline scores 
score4Baseline_cv <- score5Baseline_cv <- rep(NA,nrow(bDat)) 
 
for(s in 1:10) { 
   bDat_train <- bDat[-which(samples==s),] 
   bDat_test <- bDat[which(samples==s),] 
           
   mod <- coxph(Surv(time=time, event= deathEver) ~ log(bili) + log(protime) + edema + albumin + age,   
      data=bDat_train )          
   riskVals <- predict(mod, type="risk", newdata= bDat_test) 
   score5Baseline_cv[which(samples==s)] <- riskVals 
        
   mod <- coxph(Surv(time=time, event= deathEver) ~ log(protime) + edema + albumin + age, data=bDat_train )          
   riskVals <- predict(mod, type="risk", newdata= bDat_test) 
   score4Baseline_cv[which(samples==s)] <- riskVals 
} 
bDat$score4baseline <- score4Baseline_cv 
bDat$score5baseline <- score5Baseline_cv 
 
 
#Fit model on all baseline data, use for prediction of time-varying score 
coxMod5baseline <- coxph(Surv(time=time, event= deathEver) ~ log(bili) + log(protime) + edema + albumin + 
age, data= bDat) 
pbc2$score5tv <- predict(coxMod5baseline, type="risk", newdata= pbc2) 
 
coxMod4baseline <- coxph(Surv(time=time, event= deathEver) ~ log(protime) + edema + albumin + age, data= 
bDat) 
pbc2$score4tv <- predict(coxMod4baseline, type="risk", newdata= pbc2) 
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#####Table 2 
##A. AUC_I/D 
tableAUC_ID <- matrix(nrow=2, ncol=length(landmarkTimes)) 
tableAUC_TV_ID <- matrix(nrow=2, ncol=length(landmarkTimes)) 
 
#Baseline risk scores 
scores <- c("score4baseline","score5baseline") 
for(i in 1:length(scores)) { 
   currVar <- eval(parse(text=paste("bDat$", scores[i],sep="")))   
   mmm <- MeanRank( survival.time= bDat$time, survival.status= bDat$deathEver, marker= currVar ) 
   bandwidths <- 0.05 + c(1:80)/200 
   IMSEs <- vector(length=length(bandwidths)) 
   for(j in 1:length(bandwidths)) { 
      nnnC <- nne.CrossValidate(x=mmm$time, y=mmm$mean.rank, lambda=bandwidths[j]) #CV bandwidth 
      IMSEs[j] <- nnnC$IMSE 
   } 
   currLambdaOS <- mean(bandwidths[which(IMSEs==min(IMSEs, na.rm=T))]) 
   nnn <- nne(x= mmm$time, y= mmm$mean.rank, lambda=currLambdaOS, nControls=mmm$nControls) #Fixed bandwidth 
   tableAUC_ID[i,] <- sapply(landmarkTimes, function(x){ interpolate( x = nnn$x, y=nnn$nne, target=x ) } ) 
} 
rownames(tableAUC_ID) <- scores 
colnames(tableAUC_ID) <- landmarkTimes/units 
round(tableAUC_ID, 2) 
 
#Updated (time-varying) risk scores 
scores <- c("score4tv", "score5tv") 
for(i in 1:length(scores)) { 
   currVar <- eval(parse(text=paste("pbc2$", scores[i],sep="")))   
   mmm <- MeanRank(survival.time=pbc2$tstop, survival.status=pbc2$death, marker=currVar, start=pbc2$tstart) 
   bandwidths <- 0.05 + c(1:80)/200 
   IMSEs <- vector(length=length(bandwidths)) 
   for(j in 1:length(bandwidths)) { 
      nnnC <- nne.CrossValidate(x=mmm$time, y=mmm$mean.rank, lambda=bandwidths[j]) #CV bandwidth 
43	/	54	
      IMSEs[j] <- nnnC$IMSE 
   } 
   currLambdaOS <- mean(bandwidths[which(IMSEs==min(IMSEs, na.rm=T))]) 
   nnn <- nne(x=mmm$time, y=mmm$mean.rank, lambda=currLambdaOS, nControls=mmm$nControls )  #Fixed bandwidth 
   tableAUC_TV_ID[i,] <- sapply(landmarkTimes, function(x){ interpolate( x = nnn$x, y=nnn$nne, target=x ) } 
) 
} 
rownames(tableAUC_TV_ID) <- scores 
colnames(tableAUC_TV_ID) <- landmarkTimes/units 
round(tableAUC_TV_ID, 2) 
 
#B. c-index 
round(dynamicIntegrateAUC(survival.time=bDat$time, survival.status=bDat$deathEver, 
marker=bDat$score4baseline, cutoffTime = units*10), 2) 
round(dynamicIntegrateAUC(survival.time=bDat$time, survival.status=bDat$deathEver, 
marker=bDat$score5baseline, cutoffTime = units*10), 2) 
 
round(dynamicIntegrateAUC(survival.time= pbc2$tstop, survival.status= pbc2$death, start=pbc2$tstart, 
marker=pbc2$score4tv, cutoffTime = units*10), 2) 
round(dynamicIntegrateAUC(survival.time= pbc2$tstop, survival.status= pbc2$death, start=pbc2$tstart, 
marker=pbc2$score5tv, cutoffTime = units*10), 2) 
 
#C. Sequential C/D AUCs on subsetted data at each timepoint and one year ahead to mimic landmark analysis 
units <- 365.25 
 
landmarkTimes <- c(1, 4, 6)*units 
tableAUC_CD <- matrix(nrow=4, ncol=length(landmarkTimes)) 
 
timeWindow <- 1 
 
for(j in 1:length(landmarkTimes)) { 
   currData <- subset(bDat, time >= (landmarkTimes[j])) 
   currDataTV <- subset(pbc2, tstart <= (landmarkTimes[j]) & tstop > (landmarkTimes[j])) 
 
   nobs <- nrow(currData)     
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   out1 <- survivalROC( currData$time, currData$deathEver, marker= currData$score4baseline, 
              predict.time=(landmarkTimes[j] + timeWindow*units), method="NNE", span=0.04*nobs^(-0.2)) 
   tableAUC_CD[1,j] <- out1$AUC 
 
   out1 <- survivalROC( currData$time, currData$deathEver, marker= currData$score5baseline, 
              predict.time=(landmarkTimes[j] + timeWindow*units), method="NNE", span=0.04*nobs^(-0.2)) 
   tableAUC_CD[2,j] <- out1$AUC 
 
   nobs <- nrow(currDataTV) 
   out1 <- survivalROC( currDataTV$time, currDataTV$deathEver, marker= currDataTV$score4tv,  
              predict.time=(landmarkTimes[j] + timeWindow*units), method="NNE", span=0.04*nobs^(-0.2)) 
   tableAUC_CD[3,j] <- out1$AUC     
             
   out1 <- survivalROC( currDataTV$time, currDataTV$deathEver, marker= currDataTV$score5tv,  
              predict.time=(landmarkTimes[j] + timeWindow*units), method="NNE", span=0.04*nobs^(-0.2)) 
   tableAUC_CD[4,j] <- out1$AUC 
} 
rownames(tableAUC_CD) <- c("score4baseline","score5baseline", "score4tv", "score5tv") 
colnames(tableAUC_CD) <- landmarkTimes/units 
round(tableAUC_CD, 2) 
 
 
####Bootstrap 95% CIs 
nBoot <- 500 
 
##A. Bootstrap CIs - Baseline markers/scores 
markers <- c("score4baseline","score5baseline") 
set.seed(49) 
Cindex_bstrap <- matrix(nrow=nBoot, ncol=length(markers)) 
bstrapRes <- list() 
 
for(b in 1:nBoot) { 
   currData <- bDat[sample(x=seq(1,nrow(bDat)), size=nrow(bDat), replace = T),]    
   kmfit <- survfit(Surv(time, deathEver) ~ 1, data= currData) 
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   currDataLM1 <- currData[which(currData$time >= (landmarkTimes[1])), ] 
   currDataLM2 <- currData[which(currData$time >= (landmarkTimes[2])), ] 
   currDataLM3 <- currData[which(currData$time >= (landmarkTimes[3])), ] 
 
   aucID_scores <- NULL 
   aucCD_scores <- matrix(nrow=length(scores), ncol=length(landmarkTimes)) 
 
   for(i in 1:length(markers)) { 
      currVar <- eval(parse(text=paste("currData$",markers[i],sep=""))) 
 
      ### AUC I/D 
      mmm <- MeanRank( survival.time= currData$time, survival.status= currData$deathEver, marker= currVar ) 
     nnn <- nne( x= mmm$time, y= mmm$mean.rank, lambda=0.3 )  #Fixed bandwidth 
      aucID_scores <- rbind(aucID_scores,  
         sapply(landmarkTimes, function(t){ interpolate( x = nnn$x, y=nnn$nne, target=t ) } )) 
    
      ### C-index 
      Cindex_bstrap[b,i] <- dynamicIntegrateAUC(survival.time=currData$time,  
         survival.status= currData$deathEver, marker=currVar, cutoffTime = units*10) 
    
      ### AUC C/D landmark   
      if(markers[i]=="score4baseline" | markers[i]=="score5baseline") { 
         currDataLM <- currDataLM1 
         currVecLM <- eval(parse(text=paste("currDataLM$", markers[i], sep=""))) 
         out1 <- survivalROC( currDataLM$time, currDataLM$deathEver, marker=currVecLM, 
                   predict.time=(landmarkTimes[1] + timeWindow*units), method="NNE", span=0.04*nobs^(-0.2)) 
         currDataLM <- currDataLM2 
         currVecLM <- eval(parse(text=paste("currDataLM$", markers[i], sep=""))) 
         out2 <- survivalROC( currDataLM$time, currDataLM$deathEver, marker=currVecLM, 
                   predict.time=(landmarkTimes[2] + timeWindow*units), method="NNE", span=0.04*nobs^(-0.2)) 
 
         currDataLM <- currDataLM3 
         currVecLM <- eval(parse(text=paste("currDataLM$", markers[i], sep=""))) 
         out3 <- survivalROC( currDataLM$time, currDataLM$deathEver, marker=currVecLM, 
                   predict.time=(landmarkTimes[3] + timeWindow*units), method="NNE", span=0.04*nobs^(-0.2)) 
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         aucCD_scores[i,] <- c(out1$AUC, out2$AUC, out3$AUC) 
      } 
   } 
   bstrapRes[[b]] <- list(aucID_scores=aucID_scores, aucCD_scores=aucCD_scores) 
} 
 
#Get CIs for c-indices 
Cindex_CIs <- round(apply(Cindex_bstrap, 2, quantile, probs=c(0.025,0.975)),2) 
colnames(Cindex_CIs) <- markers 
Cindex_CIs 
 
#Get CIs for AUCs 
AUC_ID_CIs <- NULL 
AUC_CD_CIs <- NULL 
 
for(t in 1:length(landmarkTimes)) { 
   AUC_ID <- NULL 
   AUC_CD <- NULL 
   for(b in 1:nBoot) { 
      AUC_ID <- cbind( AUC_ID, bstrapRes[[b]]$aucID_scores[,t] ) 
      AUC_CD <- cbind( AUC_CD, bstrapRes[[b]]$aucCD_scores[,t] )  
   } 
   AUC_ID_CI_raw <- round( apply(AUC_ID, 1, quantile, probs=c(0.025,0.975)), 2 ) 
   AUC_CD_CI_raw <- round( apply(AUC_CD, 1, quantile, probs=c(0.025,0.975)), 2 ) 
    
   AUC_ID_CIs <- cbind(AUC_ID_CIs, sapply(seq(2), function(x) paste("(", AUC_ID_CI_raw[1,x], ", ", 
AUC_ID_CI_raw[2,x], ")", sep="" ) ) ) 
   AUC_CD_CIs <- cbind(AUC_CD_CIs, sapply(seq(2), function(x) paste("(", AUC_CD_CI_raw[1,x], ", ", 
AUC_CD_CI_raw[2,x], ")", sep="" ) ) ) 
} 
rownames(AUC_CD_CIs) <- rownames(AUC_ID_CIs) <- c("4-cov model", "5-cov model") 
colnames(AUC_CD_CIs) <- colnames(AUC_ID_CIs) <- landmarkTimes/units 
AUC_ID_CIs 
AUC_CD_CIs 
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##B. Bootstrap CIs - Time-varying scores 
markers <- c("score4tv","score5tv") 
 
set.seed(49) 
Cindex_bstrapTV <- matrix(nrow=nBoot, ncol=length(markers)) 
bstrapResTV <- list() 
 
for(b in 1:nBoot) { 
   #sample individuals 
   subjs <- unique(pbc2$id) 
   currSubjs <- sample(x=subjs, size=length(subjs), replace = T) 
   currData <- NULL 
   for(j in 1:length(currSubjs))  
      currData <- rbind(currData, pbc2[which(pbc2$id==currSubjs[j]),])  
    
   kmfit <- survfit(Surv(time=tstart, time2=tstop, event=death) ~ 1, data=currData) 
       
   currDataLM1 <- currData[which(currData$tstart<=(landmarkTimes[1]) & currData$tstop>(landmarkTimes[1])),] 
   currDataLM2 <- currData[which(currData$tstart<=(landmarkTimes[2]) & currData$tstop>(landmarkTimes[2])),] 
   currDataLM3 <- currData[which(currData$tstart<=(landmarkTimes[3]) & currData$tstop>(landmarkTimes[3])),] 
 
   aucID_scores <- NULL 
   aucCD_scores <- matrix(nrow=length(scores), ncol=length(landmarkTimes)) 
 
   for(i in 1:length(markers)) { 
      currVar <- eval(parse(text=paste("currData$", markers[i],sep=""))) 
 
      ### AUC I/D 
      mmm <- MeanRank(survival.time=currData$tstop, survival.status=currData$death, start=currData$tstart,  
         marker=currVar) 
     nnn <- nne( x= mmm$time, y= mmm$mean.rank, lambda=0.3, nControls=mmm$nControls )  #Fixed bandwidth 
      aucID_scores <- rbind(aucID_scores,  
         sapply(landmarkTimes, function(t){ interpolate( x = nnn$x, y=nnn$nne, target=t ) } )) 
 
      ### C-index 
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      Cindex_bstrapTV[b,i] <- dynamicIntegrateAUC(survival.time=currData$tstop,  
         survival.status=currData$death, start=currData$tstart, marker= currVar, cutoffTime = units*10)    
    
      ### AUC C/D landmark (for the scores only)            
         currDataLM <- currDataLM1 
         currVecLM <- eval(parse(text=paste("currDataLM$", markers[i], sep=""))) 
         out1 <- survivalROC( currDataLM$time, currDataLM$deathEver, marker=currVecLM, 
                   predict.time=(landmarkTimes[1] + timeWindow*units), method="NNE", span=0.04*nobs^(-0.2)) 
         currDataLM <- currDataLM2 
         currVecLM <- eval(parse(text=paste("currDataLM$", markers[i], sep=""))) 
         out2 <- survivalROC( currDataLM$time, currDataLM$deathEver, marker=currVecLM, 
                   predict.time=(landmarkTimes[2] + timeWindow*units), method="NNE", span=0.04*nobs^(-0.2)) 
         currDataLM <- currDataLM3 
         currVecLM <- eval(parse(text=paste("currDataLM$", markers[i], sep=""))) 
         out3 <- survivalROC( currDataLM$time, currDataLM$deathEver, marker=currVecLM, 
                   predict.time=(landmarkTimes[3] + timeWindow*units), method="NNE", span=0.04*nobs^(-0.2)) 
         aucCD_scores[i,] <- c(out1$AUC, out2$AUC, out3$AUC) 
 
   } 
   bstrapResTV[[b]] <- list(aucID_scores, aucCD_scores) 
} 
 
#Get CIs for c-indices 
Cindex_CIs <- round(apply(Cindex_bstrapTV, 2, quantile, probs=c(0.025,0.975)), 2) 
colnames(Cindex_CIs) <- markers 
Cindex_CIs 
 
#Get CIs for AUCs 
AUC_CD_CIs <- NULL 
AUC_ID_CIs <- NULL 
 
for(t in 1:length(landmarkTimes)) { 
   AUC_CD <- NULL 
   AUC_ID <- NULL 
   for(b in 1:nBoot) { 
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      AUC_ID <- cbind( AUC_ID, bstrapResTV[[b]][[1]][,t] ) 
      AUC_CD <- cbind( AUC_CD, bstrapResTV[[b]][[2]][,t] )  
   } 
   AUC_CD_CI_raw <- round( apply(AUC_CD, 1, quantile, probs=c(0.025,0.975)), 2 ) 
   AUC_ID_CI_raw <- round( apply(AUC_ID, 1, quantile, probs=c(0.025,0.975)), 2 ) 
    
   AUC_CD_CIs <- cbind(AUC_CD_CIs, sapply(seq(2), function(x) paste("(", AUC_CD_CI_raw[1,x], ", ",  
      AUC_CD_CI_raw[2,x], ")", sep="" ) ) ) 
   AUC_ID_CIs <- cbind(AUC_ID_CIs, sapply(seq(2), function(x) paste("(", AUC_ID_CI_raw[1,x], ", ",  
      AUC_ID_CI_raw[2,x], ")", sep="" ) ) ) 
} 
rownames(AUC_CD_CIs) <- rownames(AUC_ID_CIs) <- c("4-cov model", "5-cov model") 
colnames(AUC_CD_CIs) <- colnames(AUC_ID_CIs) <- landmarkTimes/units 
AUC_ID_CIs 
AUC_CD_CIs 
 
#C-index difference 
getCindexBstrapCI <- function(nBoot, inData, markerVarName1, markerVarName2, timeVarName,  
  eventVarName, cutoffTime) { 
   set.seed(49) 
   resultStar <- vector(length=nBoot) 
   for(i in 1:nBoot) { 
      datStar <- inData[sample(seq(nrow(inData)), nrow(inData), replace=T), ] 
       
      markerVar1 <- eval(parse(text=paste("datStar$", markerVarName1, sep=""))) 
      markerVar2 <- eval(parse(text=paste("datStar$", markerVarName2, sep=""))) 
      timeVar <- eval(parse(text=paste("datStar$", timeVarName, sep=""))) 
      eventVar <- eval(parse(text=paste("datStar$", eventVarName, sep=""))) 
 
      kmfit <- survfit(Surv(timeVar, eventVar) ~ 1) 
 
      ### Marker 1 
      mmm <- MeanRank( survival.time= timeVar, survival.status= eventVar, marker= markerVar1 ) 
 
      #Get overlap between survival function and mmm 
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      meanRanks <-  mmm$mean.rank[which(mmm$time <= cutoffTime)] 
      survTimes <- mmm$time[mmm$time <= cutoffTime] 
      timeMatch <- match(survTimes, kmfit$time) 
      S_t <- kmfit$surv[timeMatch] 
 
      #Calculate weights for c-index 
      f_t <- c( 0, (S_t[-length(S_t)] - S_t[-1]) ) 
      S_tao <- S_t[length(S_t)] 
      weights <- (2*f_t*S_t)/(1-S_tao^2) 
       
      Cindex1 <- sum(meanRanks * weights) #C-index 
 
      ### Marker 2 
      mmm <- MeanRank( survival.time= timeVar, survival.status= eventVar, marker= markerVar2 ) 
 
      #Get overlap between survival function and mmm 
      meanRanks <-  mmm$mean.rank[which(mmm$time <= cutoffTime)] 
      survTimes <- mmm$time[mmm$time <= cutoffTime] 
      timeMatch <- match(survTimes, kmfit$time) 
      S_t <- kmfit$surv[timeMatch] 
 
      #Calculate weights for c-index 
      f_t <- c( 0, (S_t[-length(S_t)] - S_t[-1]) ) 
      S_tao <- S_t[length(S_t)] 
      weights <- (2*f_t*S_t)/(1-S_tao^2) 
       
      Cindex2 <- sum(meanRanks * weights) #C-index 
       
      resultStar[i] <- Cindex1 - Cindex2 
   } 
   return( quantile(resultStar, probs=c(0.025, 0.975)) ) 
} 
getCindexBstrapCI(nBoot=500, inData=bDat, markerVarName1="score5baseline", markerVarName2="score4baseline", 
   timeVarName="time", eventVarName="deathEver", cutoffTime=units*10) 
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###FIGURES 
#Figure 2 
par(mfrow=c(1,2)) 
par(ps=10) 
 
#AUC I/D 
mmmBaseline <- MeanRank(survival.time=bDat$time, survival.status=bDat$deathEver, marker=bDat$score5baseline) 
print(length(mmmBaseline$time)) 
nnnBaseline <- nne(x=mmmBaseline$time, y=mmmBaseline$mean.rank, lambda=0.2, nControls=mmmBaseline$nControls) 
plot( mmmBaseline$time, mmmBaseline$mean.rank, xlab="Time (years)", ylab=expression(AUC^"I/D"*"(t)"),  
   ylim=c(0.4,1), col="blue", pch=21, cex=.8, axes=F, xlim=c(0,11)*units) 
axis(1, at=seq(0,10,by=2)*units, labels=seq(0,10,by=2)) 
axis(2) 
box() 
abline(h=0.5, lty=2) 
lines( nnnBaseline$x, nnnBaseline$nne, col="blue", lwd=2 ) 
 
mmmBaseline <- MeanRank(survival.time=bDat$time, survival.status=bDat$deathEver, marker=bDat$score4baseline) 
print(length(mmmBaseline$time)) 
nnnBaseline <- nne(x=mmmBaseline$time, y=mmmBaseline$mean.rank, lambda=0.2, nControls=mmmBaseline$nControls)  
points( mmmBaseline$time, mmmBaseline$mean.rank, col="orange", pch=21, cex=.8 ) 
lines( nnnBaseline$x, nnnBaseline$nne, col="orange", lwd=2 ) 
 
#ROC I/D (TPR) 
fpr <- 0.1 
 
mmmBaseline <- dynamicTP( p=fpr, survival.time= bDat$time, survival.status= bDat$deathEver,  
   marker= bDat$score5baseline ) 
print(length(mmmBaseline$time)) 
nnnBaseline <- nne_TPR(x=mmmBaseline$time, y=mmmBaseline$mean.rank, lambda=0.3,  
   nControls=mmmBaseline$nControls, nCases= mmmBaseline$nCases, p=fpr, survival.time= bDat$time,  
   survival.status=bDat$deathEver, marker= bDat$score5baseline )  #Fixed bandwidth 
plot(mmmBaseline$time, mmmBaseline$mean.rank, xlab="Time (years)",  
   ylab=expression(ROC[t]^"I/D"*"(FPF=10%)"), ylim=c(0,1), col="blue", pch=21, cex=.8, axes=F,  
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   xlim=c(0,11)*units) 
axis(1, at=seq(0,10,by=2)*units, labels=seq(0,10,by=2)) 
axis(2) 
box() 
abline(h=0.5, lty=2) 
lines( nnnBaseline$x, nnnBaseline$nne, col="blue", lwd=2 ) 
 
mmmBaseline <- dynamicTP(p=fpr, survival.time=bDat$time, survival.status=bDat$deathEver,  
   marker= bDat$score4baseline ) 
print(length(mmmBaseline$time)) 
nnnBaseline <- nne_TPR( x= mmmBaseline$time, y= mmmBaseline$mean.rank, lambda=0.3,  
   nControls= mmmBaseline$nControls, nCases= mmmBaseline$nCases, p=fpr, survival.time= bDat$time,  
   survival.status= bDat$deathEver, marker= bDat$score4baseline )  #Fixed bandwidth 
points( mmmBaseline$time, mmmBaseline$mean.rank, col="orange", pch=21, cex=.8 ) 
lines( nnnBaseline$x, nnnBaseline$nne, col="orange", lwd=2 ) 
legend(x=1.5*units, y=0.9, legend=c("4 covariates", "5 covariates"), col=c("orange","blue"), lty=1, lwd=2,  
   horiz=T) 
 
#Figure 3 
mmm <- MeanRank(survival.time=pbc2$tstop, survival.status= pbc2$death, marker= currVar, start=pbc2$tstart) 
 
par(mfrow=c(1,2)) 
par(ps=10) 
 
#AUC I/D 
mmmTV <- MeanRank(survival.time=pbc2$tstop, survival.status=pbc2$death, marker=pbc2$score5tv,  
   start=pbc2$tstart) 
print(length(mmmTV$time)) 
nnn <- nne( x= mmmTV$time, y= mmmTV$mean.rank, lambda=0.2, nControls=mmmTV$nControls )   
plot( mmmTV$time, mmmTV$mean.rank, xlab="Time (years)", ylab=expression(AUC^"I/D"*"(t)"), ylim=c(0.4,1),  
   col="blue", pch=21, cex=.8, axes=F, xlim=c(0,11)*units) 
axis(1, at=seq(0,10,by=2)*units, labels=seq(0,10,by=2)) 
axis(2) 
box() 
abline(h=0.5, lty=2) 
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lines( nnn$x, nnn$nne, col="blue", lwd=2, lty=1 ) 
 
mmmTV <- MeanRank(survival.time=pbc2$tstop, survival.status=pbc2$death, marker=pbc2$score4tv,  
   start=pbc2$tstart) 
print(length(mmmTV$time)) 
nnn <- nne( x= mmmTV$time, y= mmmTV$mean.rank, lambda=0.2, nControls=mmmTV$nControls )  #Fixed bandwidth 
points( mmmTV$time, mmmTV$mean.rank, col="orange", pch=21, cex=.8) 
lines( nnn$x, nnn$nne, col="orange", lwd=2, lty=1 ) 
 
#ROC I/D (TPR) 
mmmTV <- dynamicTP( p=fpr, survival.time =pbc2$tstop, survival.status= pbc2$death, marker= pbc2$score5tv, 
start= pbc2$tstart ) 
print(length(mmmTV$time)) 
nnn <- nne_TPR(x=mmmTV$time, y=mmmTV$mean.rank, lambda=0.3, nControls=mmmTV$nControls, nCases=mmmTV$nCases,  
   p=fpr, survival.time=pbc2$tstop, survival.status= pbc2$death, marker= pbc2$score5tv, start= pbc2$tstart) 
plot( mmmTV$time, mmmTV$mean.rank, xlab="Time (years)", ylab=expression(ROC[t]^"I/D"*"(FPF=10%)"),  
   ylim=c(0,1), col="blue", pch=21, cex=.8, axes=F, xlim=c(0,11)*units) 
axis(1, at=seq(0,10,by=2)*units, labels=seq(0,10,by=2)) 
axis(2) 
box() 
abline(h=0.5, lty=2) 
lines( nnn$x, nnn$nne, col="blue", lwd=2 ) 
 
mmmTV <- dynamicTP( p=fpr, survival.time =pbc2$tstop, survival.status= pbc2$death, marker= pbc2$score4tv, 
   start=pbc2$tstart ) 
nnn <- nne_TPR(x=mmmTV$time, y=mmmTV$mean.rank, lambda=0.3, nControls=mmmTV$nControls, nCases=mmmTV$nCases, 
   p=fpr, survival.time=pbc2$tstop, survival.status=pbc2$death, marker=pbc2$score4tv, start=pbc2$tstart )   
points( mmmTV$time, mmmTV$mean.rank, col="orange", pch=21, cex=.8 ) 
lines( nnn$x, nnn$nne, col="orange", lwd=2 ) 
legend(x=2.5*units, y=0.3, legend=c("4 covariates", "5 covariates"), col=c("orange","blue"), lty=1, lwd=2, 
   horiz=T) 
 
##Figure 4: With CIs for baseline and updated risk scores from 5-covariate model using I/D approach 
par(mfrow=c(1,2)) 
par(ps=10) 
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#ROC I/D 
mmmBaseline <- MeanRank(survival.time=bDat$time, survival.status=bDat$deathEver, marker=bDat$score5baseline) 
nnnBaseline <- nne(x=mmmBaseline$time, y=mmmBaseline$mean.rank, lambda=0.2, nControls=mmmBaseline$nControls)  
plot( mmmBaseline$time, mmmBaseline$mean.rank, xlab="Time (years)", ylab=expression(AUC^"I/D"*"(t)"),  
   ylim=c(0.4,1), col="lightblue", pch=21, cex=.8, axes=F, xlim=c(0,11)*units) 
axis(1, at=seq(0,10,by=2)*units, labels=seq(0,10,by=2)) 
axis(2) 
box() 
abline(h=0.5, lty=2) 
lines( nnnBaseline$x, nnnBaseline$nne, col="blue", lwd=2 ) 
lines( nnnBaseline$x, nnnBaseline$nne + 1.96*sqrt(nnnBaseline$var), col="blue", lty=2 ) 
lines( nnnBaseline$x, nnnBaseline$nne - 1.96*sqrt(nnnBaseline$var), col="blue", lty=2 ) 
 
mmmTV <- MeanRank( survival.time= pbc2$tstop, survival.status= pbc2$death, marker= pbc2$score5tv, 
   start= pbc2$tstart ) 
nnn <- nne( x= mmmTV$time, y= mmmTV$mean.rank, lambda=0.2, nControls=mmmTV$nControls )  #Fixed bandwidth 
plot( mmmTV$time, mmmTV$mean.rank, xlab="Time (years)", ylab=expression(AUC^"I/D"*"(t)"), ylim=c(0.4,1),  
   col="lightblue", pch=21, cex=.8, axes=F, xlim=c(0,11)*units) 
axis(1, at=seq(0,10,by=2)*units, labels=seq(0,10,by=2)) 
axis(2) 
box() 
abline(h=0.5, lty=2) 
lines( nnn$x, nnn$nne, col="blue", lwd=2, lty=1 ) 
lines( nnn$x, nnn$nne + 1.96*sqrt(nnn$var), col="blue", lty=2 ) 
lines( nnn$x, nnn$nne - 1.96*sqrt(nnn$var), col="blue", lty=2 ) 	
	
